ReNewVax Ltd.
PrivateLast Round
Series A
Nov 6, 2025
Total Funding Raised
$3.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ReNewVax Ltd. operates in Healthcare & Life Sciences and is based in Liverpool. Its latest recorded funding round was a Seed round in August 2025.
ReNewVax Ltd. is a biotechnology company that develops novel protein-based vaccines targeting bacterial infections and antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReNewVax Ltd. Comparables
Compare ReNewVax Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GPN Vaccines | 83% | |
| Inventprise | 77% | |
| i-Seq Biotechnology | 75% |
For institutional investors. Book with your work email.
ReNewVax Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 6, 2025 | ||||
| Seed | Aug 8, 2025 |
For institutional investors. Book with your work email.
ReNewVax Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUBIS | Seed |
| Innovate UK | Seed |
| LYVA Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 38% MoM.
- Apr 7, 2026
Monthly visitors increased 316% MoM.
For institutional investors. Book with your work email.
ReNewVax Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReNewVax Ltd.'s valuation, stock price, and market status.
Is ReNewVax Ltd. a public or private company?
ReNewVax Ltd. is a private company.
What is the current stock price of ReNewVax Ltd.?
ReNewVax Ltd. is a private company, so its shares have no public market price. Caplight tracks ReNewVax Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReNewVax Ltd. worth (valuation)?
Valuation information for ReNewVax Ltd. is not publicly available.
Can I buy ReNewVax Ltd. stock?
ReNewVax Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReNewVax Ltd.'s last funding round?
ReNewVax Ltd.'s most recent funding round was Series A on November 6, 2025.
Who are the main investors in ReNewVax Ltd.?
Key investors in ReNewVax Ltd. include QUBIS, Innovate UK, LYVA Labs.
Will ReNewVax Ltd. IPO soon?
No public IPO plans have been announced for ReNewVax Ltd..
How can I track ReNewVax Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in ReNewVax Ltd.'s shares on secondary markets.